1eb2: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:1eb2. | {{Seed}} | ||
[[Image:1eb2.png|left|200px]] | |||
<!-- | <!-- | ||
Line 9: | Line 10: | ||
{{STRUCTURE_1eb2| PDB=1eb2 | SCENE= }} | {{STRUCTURE_1eb2| PDB=1eb2 | SCENE= }} | ||
===TRYPSIN INHIBITOR COMPLEX (BPO)=== | |||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_11881991}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 11881991 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_11881991}} | |||
==About this Structure== | ==About this Structure== | ||
Line 30: | Line 34: | ||
[[Category: Inhibitor]] | [[Category: Inhibitor]] | ||
[[Category: Serine protease]] | [[Category: Serine protease]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 1 00:26:08 2008'' |
Revision as of 00:26, 1 July 2008
TRYPSIN INHIBITOR COMPLEX (BPO)TRYPSIN INHIBITOR COMPLEX (BPO)
Template:ABSTRACT PUBMED 11881991
About this StructureAbout this Structure
1EB2 is a Single protein structure of sequence from Bos taurus. Full crystallographic information is available from OCA.
ReferenceReference
PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors., Liebeschuetz JW, Jones SD, Morgan PJ, Murray CW, Rimmer AD, Roscoe JM, Waszkowycz B, Welsh PM, Wylie WA, Young SC, Martin H, Mahler J, Brady L, Wilkinson K, J Med Chem. 2002 Mar 14;45(6):1221-32. PMID:11881991
Page seeded by OCA on Tue Jul 1 00:26:08 2008